1428790-40-2

Upstream product

• 1402585-20-9 2-(4-cyano-3-fluorophenyl)propanoic acid 
• 1402585-19-6 ethyl 2-(4-cyano-3-fluorophenyl)propanoate 
• 1402585-18-5 ethyl 2-(3-fluoro-4-iodophenyl)propanoate 
• 95037-98-2 ethyl 2-(4-amino-3-fluorophenyl)propionate 
• 78543-07-4 ethyl 2-(3-fluoro-4-nitrophenyl)propionate 
• 935518-29-9 (2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)methanamine 
• 1428790-39-9 2-(4-cyano-3-fluorophenyl)-N-((2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)methyl)propanamide 

Downstream Products

• 1428790-04-8 2-(3-fluoro-4-((sulfamoylamino)methyl)phenyl)-N-((2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)methyl)propanamide 
• 1428790-41-3 tert-butyl N-(2-fluoro-4-(1-((2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)methylamino)-1-oxopropan-2-yl)benzyl)sulfamoylcarbamate 

Relevant academic research and scientific papers

AMINE SUBSTITUTED METHANESULFONAMIDE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS

The invention relates to amine substituted methanesulfonamide derivatives of formula (I) as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

Amine Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands

The invention relates to amine substituted methanesulfonamide derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.